| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Inhib (Mean) |
-32.16 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Adhesion G-protein coupled receptor F1 |
%Max (Mean) |
5.283 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Inhib (Mean) |
4.4 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
%Max (Mean) |
19.1 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Apelin receptor |
%Inhib (Mean) |
-13.89 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Apelin receptor |
%Max (Mean) |
-1.332 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Inhib (Mean) |
-8.16 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Beta-2 adrenergic receptor |
%Max (Mean) |
-2.97 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Bromodomain-containing protein 4 |
Delta TM |
0.08717 |
C |
None |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Inhib (Mean) |
-44.67 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C5a anaphylatoxin chemotactic receptor |
%Max (Mean) |
-0.5676 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Caco-2 |
Papp |
0.147 |
10^-6 cm/s |
10.1016/j.bmc.2007.04.042 |
| Homo sapiens |
Caco-2 |
Stability |
5.0 |
% |
10.1016/j.bmc.2007.04.042 |
| Homo sapiens |
Caco-2 |
T1/2 |
0.05 |
hr |
10.1016/j.bmc.2007.04.042 |
| Homo sapiens |
Casein kinase I delta |
Delta TM |
0.02561 |
C |
None |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Inhib (Mean) |
-12.71 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
%Max (Mean) |
-2.745 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Cyclin-dependent kinase 2 |
Delta TM |
0.09109 |
C |
None |
| Homo sapiens |
Fibroblast |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast |
Growth Rate |
1.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Fibroblast growth factor receptor 3 |
Delta TM |
0.1223 |
C |
None |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Inhib (Mean) |
-31.32 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
%Max (Mean) |
0.53 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Inhib (Mean) |
-36.62 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
%Max (Mean) |
8.743 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Delta TM |
-0.6781 |
C |
None |
| Homo sapiens |
G-protein coupled receptor 120 |
%Inhib (Mean) |
-39.5 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 120 |
%Max (Mean) |
-1.7 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 35 |
%Inhib (Mean) |
-12.5 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
G-protein coupled receptor 35 |
%Max (Mean) |
10.82 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
HEK-293T |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
HEK-293T |
Growth Rate |
1.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Lipoxin A4 receptor |
%Inhib (Mean) |
-27.04 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Lipoxin A4 receptor |
%Max (Mean) |
-3.23 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
MAP kinase ERK2 |
Delta TM |
0.2422 |
C |
None |
| Homo sapiens |
Peregrin |
Delta TM |
0.2166 |
C |
None |
| Homo sapiens |
Plasma |
T1/2 |
0.03333 |
hr |
10.1016/j.bmc.2015.07.022 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Delta TM |
0.1767 |
C |
None |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Inhib (Mean) |
7.4 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Sphingosine 1-phosphate receptor Edg-1 |
%Max (Mean) |
6.18 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Thyrotropin-releasing hormone receptor |
EC50 |
3.0 |
nM |
10.1016/j.bmc.2006.09.045 |
| Homo sapiens |
Thyrotropin-releasing hormone receptor |
Ki |
20.0 |
nM |
10.1016/j.bmc.2006.09.045 |
| Homo sapiens |
Transcription intermediary factor 1-alpha |
Delta TM |
-0.3853 |
C |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Inhib (Mean) |
-36.11 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Type-1 angiotensin II receptor |
%Max (Mean) |
5.701 |
% |
10.6019/CHEMBL5209801 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Delta TM |
-0.164 |
C |
None |
| Homo sapiens |
U2OS |
Growth Rate |
0.0 |
None |
10.6019/CHEMBL4689842 |
| Homo sapiens |
U2OS |
Growth Rate |
1.0 |
None |
10.6019/CHEMBL4689842 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/0960-894X(96)00478-7 |
| Mus musculus |
Mus musculus |
Inhibition |
51.1 |
% |
10.1016/j.bmc.2015.07.022 |
| Mus musculus |
Mus musculus |
Inhibition |
51.14 |
% |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Mus musculus |
Mean latency |
20.85 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
Mean latency |
25.76 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
Mean latency |
28.87 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
Mean latency |
32.69 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
Mean latency |
33.57 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
Mean latency |
37.97 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
Mean latency |
43.08 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
Mean latency |
46.0 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
Mean latency |
50.59 |
s |
10.1021/jm00015a009 |
| Mus musculus |
Mus musculus |
RRT |
34.1 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
RRT |
40.8 |
s |
10.1021/jm00111a013 |
| Mus musculus |
Mus musculus |
RRT |
40.8 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
RRT |
44.0 |
s |
10.1021/jm980333v |
| Mus musculus |
Mus musculus |
RRT |
100.1 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
RRT |
173.0 |
s |
10.1021/jm980333v |
| Mus musculus |
Mus musculus |
Sleeping time |
24.8 |
min |
10.1021/jm00159a015 |
| Mus musculus |
Mus musculus |
Sleeping time |
26.0 |
min |
10.1021/jm020531t |
| Mus musculus |
Mus musculus |
Sleeping time |
377.0 |
s |
10.1021/jm980333v |
| Mus musculus |
Mus musculus |
Sleeping time |
663.0 |
s |
10.1021/jm980333v |
| Mus musculus |
Mus musculus |
SMT |
40.9 |
s |
10.1021/jm00111a013 |
| Mus musculus |
Mus musculus |
SMT |
40.9 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
SMT |
48.2 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
SMT |
118.2 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
ST |
70.7 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
ST |
73.2 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
ST |
83.1 |
s |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
SVT |
43.4 |
% |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
SVT |
43.4 |
None |
10.1021/jm00111a013 |
| Mus musculus |
Mus musculus |
SVT |
47.1 |
% |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
SVT |
83.8 |
% |
10.1021/jm00111a014 |
| Mus musculus |
Mus musculus |
SVT |
nan |
None |
10.1021/jm00111a013 |
| Mus musculus |
Thyrotropin-releasing hormone-degrading ectoenzyme |
Drug degradation |
75.0 |
% |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone-degrading ectoenzyme |
Drug degradation |
80.0 |
% |
10.1016/j.bmc.2015.07.022 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
Activity |
334.0 |
cpm |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
Activity |
393.0 |
cpm |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
Activity |
513.46 |
cpm |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
Activity |
719.25 |
cpm |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
EC50 |
0.49 |
nM |
10.1016/s0960-894x(98)00567-8 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
EC50 |
0.68 |
nM |
10.1021/jm960053k |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
EC50 |
1.0 |
nM |
10.1016/j.bmc.2015.07.022 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
EC50 |
1.0 |
nM |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
EC50 |
3.2 |
nM |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
IC50 |
2.6 |
nM |
10.1016/j.bmc.2015.07.022 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
IC50 |
26.0 |
nM |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
Ki |
10.0 |
nM |
10.1021/jm960053k |
| Mus musculus |
Thyrotropin-releasing hormone receptor |
Ki |
23.0 |
nM |
10.1016/s0960-894x(98)00567-8 |
| Mus musculus |
Thyrotropin-releasing hormone receptor 2 |
EC50 |
0.5 |
nM |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor 2 |
EC50 |
0.52 |
nM |
10.1016/j.bmc.2015.07.022 |
| Mus musculus |
Thyrotropin-releasing hormone receptor 2 |
EC50 |
3.1 |
nM |
10.1016/j.ejmech.2016.01.038 |
| Mus musculus |
Thyrotropin-releasing hormone receptor 2 |
IC50 |
7.0 |
nM |
10.1016/j.bmc.2015.07.022 |
| Mus musculus |
Thyrotropin-releasing hormone receptor 2 |
IC50 |
7.0 |
nM |
10.1016/j.ejmech.2016.01.038 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
3013.1 |
nM |
None |
| Rattus norvegicus |
Plasma |
Cp |
4.83 |
ng/ml |
10.1016/j.bmc.2015.07.022 |
| Rattus norvegicus |
Plasma |
Cp |
6.06 |
ng/ml |
10.1016/j.bmc.2015.07.022 |
| Rattus norvegicus |
Plasma |
Cp |
6.8 |
ng/ml |
10.1016/j.bmc.2015.07.022 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
100.0 |
% |
10.1021/jm00159a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
113.0 |
mg.kg-1 |
10.1021/jm00159a015 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
113.0 |
mg.kg-1 |
10.1021/jm00372a006 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
40.0 |
% |
10.1021/jm00159a015 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
40.0 |
% |
10.1021/jm00372a006 |
| Rattus norvegicus |
Rattus norvegicus |
Maximal change |
394.0 |
% |
10.1021/jm020531t |
| Rattus norvegicus |
Rattus norvegicus |
Relative activity |
100.0 |
% |
10.1021/jm00136a003 |
| Rattus norvegicus |
Rattus norvegicus |
Serum TSH |
59.1 |
ug 100ml-1 |
10.1021/jm00170a014 |
| Rattus norvegicus |
Rattus norvegicus |
Serum TSH |
114.7 |
ug 100ml-1 |
10.1021/jm00170a014 |
| Rattus norvegicus |
Rattus norvegicus |
Serum TSH |
350.8 |
ug 100ml-1 |
10.1021/jm00170a014 |
| Rattus norvegicus |
Sigma opioid receptor |
NT |
nan |
None |
10.1021/jm980333v |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor |
EC50 |
3.0 |
nM |
10.1021/jm0505462 |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor |
Ki |
20.0 |
nM |
10.1021/jm0505462 |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor |
Ki |
42.3 |
nM |
10.1021/jm020531t |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor 2 |
EC50 |
3.0 |
nM |
10.1016/j.bmc.2006.09.045 |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor 2 |
EC50 |
3.0 |
nM |
10.1021/jm0505462 |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor 2 |
IC50 |
23.0 |
nM |
10.1021/np070658r |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor 2 |
IC50 |
23000.0 |
nM |
10.1021/np0706567 |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor 2 |
Ki |
10.0 |
nM |
10.1016/j.bmc.2006.09.045 |
| Rattus norvegicus |
Thyrotropin-releasing hormone receptor 2 |
Ki |
10.0 |
nM |
10.1021/jm0505462 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.04354 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.1003 |
None |
10.1101/2020.04.03.023846 |
| Sus scrofa |
Thyrotropin releasing hormone degrading enzyme |
Activity |
2.54 |
U/mg |
None |
| Sus scrofa |
Thyrotropin releasing hormone degrading enzyme |
Km |
35000.0 |
nM |
None |
| Sus scrofa |
Thyrotropin releasing hormone degrading enzyme |
Vmax |
2.63 |
U/mg |
None |
| Sus scrofa |
Thyrotropin releasing hormone degrading enzyme |
Vmax/Km |
0.08 |
U/mg/uM |
None |
| None |
ADMET |
K''IAM |
0.51 |
None |
10.1021/jm020531t |
| None |
ADMET |
T1/2 |
0.1833 |
hr |
10.1021/jm020531t |
| None |
ADMET |
T1/2 |
0.2667 |
hr |
10.1021/jm020531t |
| None |
No relevant target |
CLogP |
-4.37 |
None |
10.1021/jm020531t |
| None |
No relevant target |
CLogP |
-0.27 |
None |
10.1021/jm020531t |
| None |
No relevant target |
LogP |
-1.74 |
None |
10.1021/jm020531t |
| None |
Unchecked |
Ac50 |
3.162 |
uM |
None |
| None |
Unchecked |
Ac50 |
3.981 |
uM |
None |
| None |
Unchecked |
Ac50 |
28.18 |
uM |
None |
| None |
Unchecked |
AC50 |
3162.3 |
nM |
None |
| None |
Unchecked |
AC50 |
3981.1 |
nM |
None |
| None |
Unchecked |
AC50 |
28190.0 |
nM |
None |
| None |
Unchecked |
Activity |
100.0 |
% |
10.1021/jm00372a006 |
| None |
Unchecked |
Ratio |
1.0 |
None |
10.1021/jm00170a014 |
| None |
Unchecked |
Ratio EC50 |
1.0 |
None |
10.1016/j.ejmech.2016.01.038 |
| None |
Unchecked |
Ratio EC50 |
1.9 |
None |
10.1016/j.bmc.2015.07.022 |
| None |
Unchecked |
Ratio EC50 |
2.0 |
None |
10.1016/j.ejmech.2016.01.038 |
| None |
Unchecked |
Ratio IC50 |
3.7 |
None |
10.1016/j.ejmech.2016.01.038 |
| None |
Unchecked |
Selectivity |
2.0 |
None |
10.1021/jm0505462 |